Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1159351
- By:
- Publication type:
- Article
Works by Seiffert-Sinha, Kristina
Results: 16
1
2
A retrospective analysis of patient-reported physical and psychological stressors as trigger factors in autoimmune bullous disease.
- Published in:
- 2024
- By:
- Publication type:
- Letter
3
Increased oxidative stress in pemphigus vulgaris is related to disease activity and HLA-association.
- Published in:
- Autoimmunity, 2016, v. 49, n. 4, p. 248, doi. 10.3109/08916934.2016.1145675
- By:
- Publication type:
- Article
4
Specific immunoglobulin isotypes correlate with disease activity, morphology, duration and HLA association in Pemphigus vulgaris.
- Published in:
- Autoimmunity, 2012, v. 45, n. 7, p. 516, doi. 10.3109/08916934.2012.702811
- By:
- Publication type:
- Article
5
Inheritance-Specific Dysregulation of Th1- and Th17-Associated Cytokines in Alopecia Areata.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 9, p. 1285, doi. 10.3390/biom13091285
- By:
- Publication type:
- Article
6
A comprehensive, population level evaluation of previously reported drug triggers of pemphigus highlights immunomodulatory capacity as a common characteristic.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2024.1508129
- By:
- Publication type:
- Article
7
Healthy individuals genetically at-risk for the development of Pemphigus vulgaris or Alopecia areata share disease-like cytokine dysregulation.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2024.1500284
- By:
- Publication type:
- Article
8
Evaluation of link between COVID-19 adjacent spike in hydroxychloroquine use and increased reports of pemphigus: a disproportionality analysis of the FDA Adverse Event Reporting System.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2024.1470660
- By:
- Publication type:
- Article
9
Cytokine profiling reveals HLA-linked Th2 and Th17 driven immune activation in pemphigus vulgaris patients and genetically susceptible healthy controls.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1500231
- By:
- Publication type:
- Article
10
Evolutionary context of psoriatic immune skin response.
- Published in:
- Evolution, Medicine & Public Health, 2021, v. 2021, n. 1, p. 474, doi. 10.1093/emph/eoab042
- By:
- Publication type:
- Article
11
Development of a Disease Registry for Autoimmune Bullous Diseases: Initial Analysis of the Pemphigus Vulgaris Subset.
- Published in:
- Acta Dermato-Venereologica, 2015, v. 95, n. 1, p. 86, doi. 10.2340/00015555-1854
- By:
- Publication type:
- Article
12
Modulation of Mechanical Stress Mitigates Anti-Dsg3 Antibody-Induced Dissociation of Cell--Cell Adhesion.
- Published in:
- Advanced Biology, 2021, v. 5, n. 1, p. 1, doi. 10.1002/adbi.202000159
- By:
- Publication type:
- Article
13
HLA- E*0103 X is associated with susceptibility to Pemphigus vulgaris.
- Published in:
- Experimental Dermatology, 2013, v. 22, n. 2, p. 108, doi. 10.1111/exd.12077
- By:
- Publication type:
- Article
14
Nanorobotic Investigation Identifies Novel Visual, Structural and Functional Correlates of Autoimmune Pathology in a Blistering Skin Disease Model.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0106895
- By:
- Publication type:
- Article
15
Patient genetics shape the autoimmune response in the blistering skin disease pemphigus vulgaris.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 01, doi. 10.3389/fimmu.2022.1064073
- By:
- Publication type:
- Article
16
Case report: Documentation of cutaneous only pemphigus vulgaris without history of mucosal lesions in North America.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2022.969279
- By:
- Publication type:
- Article